At the University of Maryland, Baltimore, researchers are using a practical method, bacterial enzymatic combinatorial chemistry (BECC), to generate functionally diverse molecules that can potentially be used as adjuvants.

A study published this week in mBio demonstrates that a novel technique can be used to build better vaccines for infectious diseases. The study shows that a practical method, bacterial enzymatic combinatorial chemistry (BECC), can be used to generate functionally diverse molecules that can potentially be used as adjuvants

Bypassing the slow growth of Mycobacterium tuberculosis with computer models provides new ways to learn about the disease.

The ASM joined over 350 organizations in a letter to President Donald Trump expressing support for the safety of vaccines. 

Researchers discuss current efforts underway and the most recent developments on the road to a universal flu vaccine.

Bruce Weniger, Associate Editor of the journal Vaccine discusses the latest research on cutaneous vaccination.

Clostridium difficile infection is an important cause of intestinal disease, primarily affecting hospitalized patients exposed to antibiotics. Participants discuss this disturbing trend as well as the potential role of animals and the food supply and the status of current vaccine development efforts.